Allgenesis Announces Encouraging Safety and Efficacy Data from the AG-73305
08 Nov 2023 //
PR NEWSWIRE
Allgenesis unveils encouraging data from trial of dry eye disease therapy
20 Jun 2023 //
CLINICAL TRIALS ARENA
Allgenesis Announces Encouraging Ph1b Data AG-80308 Providing Improvements
19 Jun 2023 //
PR NEWSWIRE
Allgenesis touts preliminary data from Phase IIa diabetic macular oedema trial
24 May 2023 //
CLINICAL TRIALS ARENA
Allgenesis Announces afety and Efficacy Data from te AG-73305
23 May 2023 //
PR NEWSWIRE